Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¤À¾Áö¿ª¿¡¼­ÀÇ Àü¸³¼±ºñ´ëÁõ À¯º´À²ÀÇ ¿ªÇÐÁ¶»ç Prevalence of Benign Prostatic Hyperplasia in Jeong-Eup Area: Community-based Study

´ëÇѺñ´¢±â°úÇÐȸÁö 1999³â 40±Ç 1È£ p.52 ~ 58
Á¤Å±Ô, Á¤Áø¼ö, ÀÌ»ó¿­, ¾ÈÇÑÁ¾,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤Å±Ԡ(  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Á¤Áø¼ö (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
À̻󿭠(  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
¾ÈÇÑÁ¾ (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç

Abstract

°á·Ð
º» ¿¬±¸¿¡¼­´Â ¿ì¸® ³ª¶ó¿¡¼­ÀÇ Àü¸³¼±ºñ´ëÁõÀÇ À¯º´À²À» ÃßÁ¤Çϱâ À§ÇÏ¿© Àü¶óºÏµµ Á¤À¾
Áö¿ª¿¡¼­ Àü¸³¼±Áõ»óÁö¼ö¸¦ ÀÌ¿ëÇÑ ¼³¹®Á¶»ç¿Í Á÷Àå¼öÁö°Ë»ç, ¿ä¼Ó°Ë»ç¸¦ ½ÃÇàÇÏ¿´´Ù. Àü¸³
¼±Áõ»óÁö¼öÀÇ °¢ Áõ»ó Áß ¾ß°£´¢¿Í ¼¼´¢°¡ °¡Àå ÈçÇÑ Áõ»óÀ̾úÀ¸¸ç Á¶»ç´ë»óÀÇ 49.5%¿¡¼­
Áß°£ ÀÌ»óÀÇ Àü¸³¼±Áõ»óÀ» º¸¿´°í, Àü±¹Àα¸¿¡¼­ÀÇ Ç¥ÁØÈ­À¯º´À²Àº 44.7%·Î ÀÌ´Â ´Ù¸¥ ¿¬±¸
ÀÇ °á°ú¿Í À¯»çÇÏ¿´´Ù. Àü¸³¼±ºñ´ëÁõÀÇ ÀÓ»óÀû ÁöÇ¥·Î »ç¿ëµÇ´Â Àü¸³¼±Áõ»óÀ̳ª Àü¸³¼±Å©±â
±×¸®°í ÃÖ°í¿ä¼ÓÀº ¼­·Î »ó°ü°ü°è°¡ ¾ø¾î ¾î´À ÇÑ°¡Áö ÁöÇ¥·Î¼­ ÀÓ»óÀû ÀÇÀǸ¦ °®´Â Àü¸³¼±
ºñ´ëÁõÀÇ À¯º´À²À» ÃßÁ¤Çϱâ´Â ¾î·Á¿ï °ÍÀ¸·Î »ý°¢µÈ´Ù. Áߵ ÀÌ»óÀÇ Àü¸³¼±Áõ»óÀ» °¡Áö
¸ç Àü¸³¼±ÀÇ ºñ´ë¿Í ÇÔ²² ¿ä¼ÓÀÇ °¨¼Ò¸¦ º¸ÀÌ´Â ÀÓ»óÀû Àü¸³¼±ºñ´ëÁõÀº 50¼¼ ÀÌ»ó ³²ÀÚÀÇ
11.1%¿´´Ù(8.7-13.5%, 95%½Å·Ú±¸°£). ÀÌ °á°ú·Î Çѱ¹¿¡¼­ÀÇ Àü¸³¼±ºñ´ëÁõÀÇ À¯º´À²Àº ¹éÀÎ
¿¡ ºñÇÏ¿© ³·À¸¸ç, Çѱ¹ÀÇ 50¼¼ ÀÌ»ó ³²ÀÚ Áß 1995³âµµ Àα¸¸¦ ±âÁØÀ¸·Î ¾à 160¸¸¸í(44%)ÀÌ
Áߵ ÀÌ»óÀÇ Àü¸³¼±Áõ»óÀ» °¡Áö°íÀÖ°í, À̵é Áß ¾à 30¸¸¸í(8.7%)ÀÌ ¿ä¼ÓÀÇ °¨¼Ò¿Í ÇÔ²²
Àü¸³¼± Å©±â°¡ Ä¿Á® ÀÖ´Â ÀÓ»óÀû ÀÇÀǸ¦ °®´Â Àü¸³¼±ºñ´ëÁõÀÏ °ÍÀ¸·Î ÃßÁ¤µÈ´Ù.

Purpose: There is no consensus about a definition of benign prostatic hyperplasia, but
there are various definitions based on a combination of clinical parameters used to
describe the properties of BPH: symptoms of prostatism, increase of prostate volume,
and bladder outlet obstruction. The prevalence of clinical BPH in Asian was believed to
be lower than Caucasian. The lower urinary tract symptoms associated with BPH in
Korea was reported by some authors and it was similar to the results of other studies
in western countries. We report the prevalence of BPH in Korean men through a
community-based study in Jeong-Eup county, Korea.
Materials and Methods: A total of 653 men aged 50 and over in Jeong-Eup area,
Korea was randomly selected for determination of the prevalence of BPH. The definition
of BPH in this study was combination of moderate(8-19) to severe(>19) ¥°-PSS,
enlargement of the prostate over 30gms on digital rectal examination by one board
certified urologist, and decreased peak flow rate below 15§¢/sec. Men with abnormal
digital rectal examination(DRE) and elevated serum prostate specific antigen(PSA) above
3.5ng/§¢ were undergone sextant prostate biopsy to exclude the prostate cancer.
Results: ¥°-PSS questionnaires were completed in 431 men and the response rate was
66.1%. Based on ¥°-PSS, 162 men(37.6%) had moderate symptoms and 51 men(11.9%)
severe symptoms. Of 213 men with moderate to severe symptoms, 35.7% had enlarged
prostate by DRE, and 63.1% decreased flow rate. The prevalence of BPH by the
definition in this study was 4.3% in their fifties, 13.2% in sixties and 16.3% in seventies
and over eighty(overall, 11.1%). The population-adjusted prevalence of BPH in Korean
men aged 50 and over was 8.7%. A good correlation was found between the total
symptom score and the quality of life score that is included in the ¥°-PSS.
Conclusions: Men with moderate to severe ¥°-PSS was 49.5%, which was similar to
the results from other studies in Caucasian and Japanese. The prevalence of BPH in
Korea by aforementioned definition was 8.7%, which seems to be lower than Caucasian.
This results suggest that approximately 1,600,000 Korean men had moderate to severe
urinary symptoms and 300,000 clinical BPH by the definition in this study.

Å°¿öµå

Benign prostatic hyperplasia; Prevalence; Voiding symptoms;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS